Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.

NCT01604161 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01604161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open Label, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Child Patients With GHD or Turner Short Stature Without Closure of Epiphyseal Discs.
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
May 31, 2005
Completion date
June 30, 2015
Enrollment
2,016 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disorder, growth hormone deficiency in children, growth hormone disorder, turner syndrome